299 related articles for article (PubMed ID: 19737935)
1. Suppression of long chain acyl-CoA synthetase 3 decreases hepatic de novo fatty acid synthesis through decreased transcriptional activity.
Bu SY; Mashek MT; Mashek DG
J Biol Chem; 2009 Oct; 284(44):30474-83. PubMed ID: 19737935
[TBL] [Abstract][Full Text] [Related]
2. Hepatic long-chain acyl-CoA synthetase 5 mediates fatty acid channeling between anabolic and catabolic pathways.
Bu SY; Mashek DG
J Lipid Res; 2010 Nov; 51(11):3270-80. PubMed ID: 20798351
[TBL] [Abstract][Full Text] [Related]
3. Distinct transcriptional regulation of long-chain acyl-CoA synthetase isoforms and cytosolic thioesterase 1 in the rodent heart by fatty acids and insulin.
Durgan DJ; Smith JK; Hotze MA; Egbejimi O; Cuthbert KD; Zaha VG; Dyck JR; Abel ED; Young ME
Am J Physiol Heart Circ Physiol; 2006 Jun; 290(6):H2480-97. PubMed ID: 16428347
[TBL] [Abstract][Full Text] [Related]
4. Ontogeny of mRNA expression and activity of long-chain acyl-CoA synthetase (ACSL) isoforms in Mus musculus heart.
de Jong H; Neal AC; Coleman RA; Lewin TM
Biochim Biophys Acta; 2007 Jan; 1771(1):75-82. PubMed ID: 17197235
[TBL] [Abstract][Full Text] [Related]
5. High-fructose diet downregulates long-chain acyl-CoA synthetase 3 expression in liver of hamsters via impairing LXR/RXR signaling pathway.
Dong B; Kan CF; Singh AB; Liu J
J Lipid Res; 2013 May; 54(5):1241-54. PubMed ID: 23427282
[TBL] [Abstract][Full Text] [Related]
6. Liver-specific loss of long chain acyl-CoA synthetase-1 decreases triacylglycerol synthesis and beta-oxidation and alters phospholipid fatty acid composition.
Li LO; Ellis JM; Paich HA; Wang S; Gong N; Altshuller G; Thresher RJ; Koves TR; Watkins SM; Muoio DM; Cline GW; Shulman GI; Coleman RA
J Biol Chem; 2009 Oct; 284(41):27816-27826. PubMed ID: 19648649
[TBL] [Abstract][Full Text] [Related]
7. Long-chain acyl-CoA synthetase 1 interacts with key proteins that activate and direct fatty acids into niche hepatic pathways.
Young PA; Senkal CE; Suchanek AL; Grevengoed TJ; Lin DD; Zhao L; Crunk AE; Klett EL; Füllekrug J; Obeid LM; Coleman RA
J Biol Chem; 2018 Oct; 293(43):16724-16740. PubMed ID: 30190326
[TBL] [Abstract][Full Text] [Related]
8. Hepatic expression of long-chain acyl-CoA synthetase 3 is upregulated in hyperlipidemic hamsters.
Wu M; Liu H; Chen W; Fujimoto Y; Liu J
Lipids; 2009 Nov; 44(11):989-98. PubMed ID: 19756806
[TBL] [Abstract][Full Text] [Related]
9. Coordinate regulation of the expression of the fatty acid transport protein and acyl-CoA synthetase genes by PPARalpha and PPARgamma activators.
Martin G; Schoonjans K; Lefebvre AM; Staels B; Auwerx J
J Biol Chem; 1997 Nov; 272(45):28210-7. PubMed ID: 9353271
[TBL] [Abstract][Full Text] [Related]
10. Long chain acyl-CoA synthetase-3 is a molecular target for peroxisome proliferator-activated receptor delta in HepG2 hepatoma cells.
Cao A; Li H; Zhou Y; Wu M; Liu J
J Biol Chem; 2010 May; 285(22):16664-74. PubMed ID: 20308079
[TBL] [Abstract][Full Text] [Related]
11. Rat long chain acyl-CoA synthetase 5 increases fatty acid uptake and partitioning to cellular triacylglycerol in McArdle-RH7777 cells.
Mashek DG; McKenzie MA; Van Horn CG; Coleman RA
J Biol Chem; 2006 Jan; 281(2):945-50. PubMed ID: 16263710
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional activation of hepatic ACSL3 and ACSL5 by oncostatin m reduces hypertriglyceridemia through enhanced beta-oxidation.
Zhou Y; Abidi P; Kim A; Chen W; Huang TT; Kraemer FB; Liu J
Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2198-205. PubMed ID: 17761945
[TBL] [Abstract][Full Text] [Related]
13. Regulation of putative fatty acid transporters and Acyl-CoA synthetase in liver and adipose tissue in ob/ob mice.
Memon RA; Fuller J; Moser AH; Smith PJ; Grunfeld C; Feingold KR
Diabetes; 1999 Jan; 48(1):121-7. PubMed ID: 9892232
[TBL] [Abstract][Full Text] [Related]
14. SREBP2 Activation Induces Hepatic Long-chain Acyl-CoA Synthetase 1 (ACSL1) Expression in Vivo and in Vitro through a Sterol Regulatory Element (SRE) Motif of the ACSL1 C-promoter.
Singh AB; Kan CF; Dong B; Liu J
J Biol Chem; 2016 Mar; 291(10):5373-84. PubMed ID: 26728456
[TBL] [Abstract][Full Text] [Related]
15. Long-Chain Acyl-CoA Synthetase 4-Mediated Fatty Acid Metabolism Sustains Androgen Receptor Pathway-Independent Prostate Cancer.
Ma Y; Zhang X; Alsaidan OA; Yang X; Sulejmani E; Zha J; Beharry Z; Huang H; Bartlett M; Lewis Z; Cai H
Mol Cancer Res; 2021 Jan; 19(1):124-135. PubMed ID: 33077484
[TBL] [Abstract][Full Text] [Related]
16. Molecular Characterization, Tissue Distribution Profile, and Nutritional Regulation of
Yang Z; Zhu H; Huang X; Wang A; Xie D
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742881
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical staining reveals differential expression of ACSL3 and ACSL4 in hepatocellular carcinoma and hepatic gastrointestinal metastases.
Ndiaye H; Liu JY; Hall A; Minogue S; Morgan MY; Waugh MG
Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32286604
[TBL] [Abstract][Full Text] [Related]
18. Induction of the fatty acid transport protein 1 and acyl-CoA synthase genes by dimer-selective rexinoids suggests that the peroxisome proliferator-activated receptor-retinoid X receptor heterodimer is their molecular target.
Martin G; Poirier H; Hennuyer N; Crombie D; Fruchart JC; Heyman RA; Besnard P; Auwerx J
J Biol Chem; 2000 Apr; 275(17):12612-8. PubMed ID: 10777552
[TBL] [Abstract][Full Text] [Related]
19. Characterization of Acyl-CoA synthetase isoforms in pancreatic beta cells: Gene silencing shows participation of ACSL3 and ACSL4 in insulin secretion.
Ansari IH; Longacre MJ; Stoker SW; Kendrick MA; O'Neill LM; Zitur LJ; Fernandez LA; Ntambi JM; MacDonald MJ
Arch Biochem Biophys; 2017 Mar; 618():32-43. PubMed ID: 28193492
[TBL] [Abstract][Full Text] [Related]
20. Long-chain acyl-CoA synthetase in fatty acid metabolism involved in liver and other diseases: an update.
Yan S; Yang XF; Liu HL; Fu N; Ouyang Y; Qing K
World J Gastroenterol; 2015 Mar; 21(12):3492-8. PubMed ID: 25834313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
